J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 1075-1084; DOI 10.1099/vir.0.81646-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cocquerel, L.
Right arrow Articles by Dubuisson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cocquerel, L.
Right arrow Articles by Dubuisson, J.
Agricola
Right arrow Articles by Cocquerel, L.
Right arrow Articles by Dubuisson, J.
© 2006 Society for General Microbiology

Review article

Hepatitis C virus entry: potential receptors and their biological functions

Laurence Cocquerel{dagger}, Cécile Voisset{dagger} and Jean Dubuisson

CNRS-UMR8161, Institut de Biologie de Lille, Institut Pasteur de Lille, 1 rue Calmette, BP447, 59021 Lille cedex, France

Correspondence
Jean Dubuisson
jean.dubuisson{at}ibl.fr

Several cellular molecules have been identified as putative receptors for Hepatitis C virus (HCV): CD81 tetraspanin, scavenger receptor class B type I (SR-BI), mannose-binding lectins DC-SIGN and L-SIGN, low-density lipoprotein receptor, heparan sulphate proteoglycans and the asialoglycoprotein receptor. Due to difficulties in propagating HCV in cell culture, most of these molecules have been identified by analysing their interaction with a soluble, truncated form of HCV glycoprotein E2. A recent major step in investigating HCV entry was the development of pseudoparticles (HCVpp), consisting of unmodified HCV envelope glycoproteins assembled onto retroviral core particles. This system has allowed the investigation of the role of candidate receptors in the early steps of the HCV life cycle and the data obtained can now be confirmed with the help of a newly developed cell-culture system that allows efficient amplification of HCV (HCVcc). Interestingly, CD81 and SR-BI have been shown to play direct roles in HCVpp and/or HCVcc entry. However, co-expression of CD81 and SR-BI in non-hepatic cell lines does not lead to HCVpp entry, indicating that other molecule(s), expressed only in hepatic cells, are necessary for HCV entry. In this review, the molecules that have been proposed as potential HCV receptors are described and the experimental data indicating that CD81 and SR-BI are potentially involved in HCV entry are presented.

Published online ahead of print on 14 February 2006 as DOI 10.1099/vir.0.81646-0.

{dagger}These authors contributed equally to this review.




This article has been cited by other articles:


Home page
J. Virol.Home page
A. K. Schwarz, J. Grove, K. Hu, C. J. Mee, P. Balfe, and J. A. McKeating
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
J. Virol., December 1, 2009; 83(23): 12407 - 12414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Charrin, S. Yalaoui, B. Bartosch, L. Cocquerel, J.-F. Franetich, C. Boucheix, D. Mazier, E. Rubinstein, and O. Silvie
The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection
J. Biol. Chem., November 13, 2009; 284(46): 31572 - 31578.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. P. Coffey, R. Rajapaksa, R. Liu, O. Sharpe, C.-C. Kuo, S. W. Krauss, Y. Sagi, R. E. Davis, L. M. Staudt, J. P. Sharman, et al.
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin
J. Cell Sci., September 1, 2009; 122(17): 3137 - 3144.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Cukierman, L. Meertens, C. Bertaux, F. Kajumo, and T. Dragic
Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts
J. Virol., June 1, 2009; 83(11): 5477 - 5484.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. E. Burlone and A. Budkowska
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
J. Gen. Virol., May 1, 2009; 90(5): 1055 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Arduise, T. Abache, L. Li, M. Billard, A. Chabanon, A. Ludwig, P. Mauduit, C. Boucheix, E. Rubinstein, and F. Le Naour
Tetraspanins Regulate ADAM10-Mediated Cleavage of TNF-{alpha} and Epidermal Growth Factor
J. Immunol., November 15, 2008; 181(10): 7002 - 7013.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-C. Meunier, R. S. Russell, R. E. Engle, K. N. Faulk, R. H. Purcell, and S. U. Emerson
Apolipoprotein C1 Association with Hepatitis C Virus
J. Virol., October 1, 2008; 82(19): 9647 - 9656.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, and S. Crotta
CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes
J. Virol., September 1, 2008; 82(17): 8316 - 8329.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. Espenel, E. Margeat, P. Dosset, C. Arduise, C. Le Grimellec, C. A. Royer, C. Boucheix, E. Rubinstein, and P.-E. Milhiet
Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web
J. Cell Biol., August 25, 2008; 182(4): 765 - 776.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Machida, Y. Kondo, J. Y. Huang, Y.-C. Chen, K. T.-H. Cheng, Z. Keck, S. Foung, J. Dubuisson, V. M.-H. Sung, and M. M. C. Lai
Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein
J. Virol., July 1, 2008; 82(13): 6711 - 6720.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Harris, M. J. Farquhar, C. J. Mee, C. Davis, G. M. Reynolds, A. Jennings, K. Hu, F. Yuan, H. Deng, S. G. Hubscher, et al.
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
J. Virol., May 15, 2008; 82(10): 5007 - 5020.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M. Jones and J. S Owen
How does interferon inhibit HCV cell entry?
Gut, May 1, 2008; 57(5): 573 - 574.
[Full Text] [PDF]


Home page
J. Virol.Home page
L. Meertens, C. Bertaux, L. Cukierman, E. Cormier, D. Lavillette, F.-L. Cosset, and T. Dragic
The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus
J. Virol., April 1, 2008; 82(7): 3555 - 3560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Yang, C. Qiu, N. Biswas, J. Jin, S. C. Watkins, R. C. Montelaro, C. B. Coyne, and T. Wang
Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus
J. Biol. Chem., March 28, 2008; 283(13): 8643 - 8653.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. M. Owsianka, A. W. Tarr, Z.-Y. Keck, T.-K. Li, J. Witteveldt, R. Adair, S. K. H. Foung, J. K. Ball, and A. H. Patel
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
J. Gen. Virol., March 1, 2008; 89(3): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. J. Mee, J. Grove, H. J. Harris, K. Hu, P. Balfe, and J. A. McKeating
Effect of Cell Polarization on Hepatitis C Virus Entry
J. Virol., January 1, 2008; 82(1): 461 - 470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dreux, B. Boson, S. Ricard-Blum, J. Molle, D. Lavillette, B. Bartosch, E.-I. Pecheur, and F.-L. Cosset
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus
J. Biol. Chem., November 2, 2007; 282(44): 32357 - 32369.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. McCaffrey, I. Boo, P. Poumbourios, and H. E. Drummer
Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding
J. Virol., September 1, 2007; 81(17): 9584 - 9590.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Lavillette, E.-I. Pecheur, P. Donot, J. Fresquet, J. Molle, R. Corbau, M. Dreux, F. Penin, and F.-L. Cosset
Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus
J. Virol., August 15, 2007; 81(16): 8752 - 8765.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Catanese, R. Graziani, T. von Hahn, M. Moreau, T. Huby, G. Paonessa, C. Santini, A. Luzzago, C. M. Rice, R. Cortese, et al.
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
J. Virol., August 1, 2007; 81(15): 8063 - 8071.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Helle, A. Goffard, V. Morel, G. Duverlie, J. McKeating, Z.-Y. Keck, S. Foung, F. Penin, J. Dubuisson, and C. Voisset
The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein
J. Virol., August 1, 2007; 81(15): 8101 - 8111.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. S. Barsoum
Hepatitis C virus: from entry to renal injury--facts and potentials
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1840 - 1848.
[Full Text] [PDF]


Home page
J. Virol.Home page
Z. Cai, L. Cai, J. Jiang, K.-S. Chang, D. R. van der Westhuyzen, and G. Luo
Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells
J. Virol., June 1, 2007; 81(11): 6128 - 6133.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Blanchet and C. Sureau
Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues
J. Virol., June 1, 2007; 81(11): 5841 - 5849.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Tscherne, M. J. Evans, T. von Hahn, C. T. Jones, Z. Stamataki, J. A. McKeating, B. D. Lindenbach, and C. M. Rice
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
J. Virol., April 15, 2007; 81(8): 3693 - 3703.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Ciczora, N. Callens, F. Penin, E.-I. Pecheur, and J. Dubuisson
Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus Entry
J. Virol., March 1, 2007; 81(5): 2372 - 2381.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann
The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells
J. Virol., January 15, 2007; 81(2): 588 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Krey, E. Moussay, H.-J. Thiel, and T. Rumenapf
Role of the Low-Density Lipoprotein Receptor in Entry of Bovine Viral Diarrhea Virus
J. Virol., November 1, 2006; 80(21): 10862 - 10867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Helle, C. Wychowski, N. Vu-Dac, K. R. Gustafson, C. Voisset, and J. Dubuisson
Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans
J. Biol. Chem., September 1, 2006; 281(35): 25177 - 25183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 by the Society for General Microbiology.